Immunostimulatory sequence CpG elicits Th1-type immune responses in inflammatory skin lesions in an atopic dermatitis murine model

International Archives of Allergy and Immunology

Volumn 147, Issue 1, 2008, Pages 41-51

  Wang, Guoying ^a   Fyhrquist Vanni, Nanna ^a   Wolff, Henrik ^a,e   Dieu Nosjean, Marie Caroline ^c   Kemeny, Lajos ^d   Homey, Bernard ^b   Lauerma, Antti I ^a   Alenius, Harri ^a  

^a FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c INSERM   (France)

^d UNIVERSITY OF SZEGED   (Hungary)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Animal model; Atopic dermatitis; Chemokines; Cytokines; Immunostimulatory sequence CpG

Indexed keywords

CHEMOKINE; CPG OLIGODEOXYNUCLEOTIDE; EOTAXIN 2; INTERLEUKIN 13; MESSENGER RNA; OVALBUMIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATOPIC DERMATITIS; CPG ISLAND; CYTOKINE PRODUCTION; DENDRITIC CELL; DERMIS; FEMALE; IMMUNE RESPONSE; IMMUNOADSORBENT; IMMUNOSTIMULATION; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN BIOPSY; SKIN INFLAMMATION; SUBCUTANEOUS TISSUE; T LYMPHOCYTE ACTIVATION; TH1 CELL; THERAPY EFFECT; TREATMENT RESPONSE;

ANIMALS; ANTIGENS, DIFFERENTIATION; CYTOKINES; DERMATITIS, ATOPIC; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MACROPHAGES; MICE; MICE, INBRED BALB C; OLIGODEOXYRIBONUCLEOTIDES; OVALBUMIN; POLYMERASE CHAIN REACTION; RNA, MESSENGER; SKIN; TH1 CELLS;

EID: 49749085134     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000128585     Document Type: Article

References (26)

1. Leung DY, Bieber T: Atopic dermatitis. Lancet 2003;361:151-160.
2. Boumpas DT, Chrousos GP, Wilder RL, et al: Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates. Ann Intern Med 1993;119:1198-1208.
3. Lubach D, Rath J, Kietzmann M: Skin atrophy induced by initial continuous topical application of clobetasol followed by intermittent application. Dermatology 1995;190:51-55.
4. Wang G, Molander G, Koivuluhta M, Alenius H, Lauerma A: Decreased in vitro cellular response to tetanus toxoid and tubulin in patients using topical corticosteroids. Acta Derm Venerol 2005;85:296-298.
5. O'Garra A: Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 1998;8:275-283.
6. Klinman DM: Immunotherapeutic uses of CpG oligodeoxynucleotides. Nat Rev Immunol 2004;4:249-258.
7. Jain VV, Kitagaki K, Businga T, et al: CpG-oligodeoxynucleotides inhibit airway remodeling in a murine model of chronic asthma. J Allergy Clin Immunol 2002;110:867-872.
8. Kline JN, Waldschmidt TJ, Businga TR, et al: Modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma. J Immunol 1998;160:2555-2559.
9. Santeliz JV, Van Nest G, Traquina P, et al: Amb a 1-linked CpG oligodeoxynucleotides reverse established airway hyperresponsiveness in a murine model of asthma. J Allergy Clin Immunol 2002;109:455-462.
10. Sur S, Wild JS, Choudhury BK, et al: Long term prevention of allergic lung inflammation in a mouse model of asthma by CpG oligodeoxynucleotides. J Immunol 1999;162:6284-6293.
11. Serebrisky D, Teper AA, Huang CK, et al: CpG oligodeoxynucleotides can reverse Th2-associated allergic airway responses and alter the B7.1/B7.2 expression in a murine model of asthma. J Immunol 2000;165:5906-5912.
12. Takabayashi K, Libet L, Chisholm D, et al: Intranasal immunotherapy is more effective than intradermal immunotherapy for the induction of airway allergen tolerance in Th2-sensitized mice. J Immunol 2003;170:3898-3905.
13. Broide D, Schwarze J, Tighe H, et al: Immunostimulatory DNA sequences inhibit IL-5, eosinophilic inflammation, and airway hyperresponsiveness in mice. J Immunol 1998;161:7054-7062.
14. Marshall JD, Abtahi S, Eiden JJ, et al: Immunostimulatory sequence DNA linked to the Amb a 1 allergen promotes T(H)1 cytokine expression while downregulating T(H)2 cytokine expression in PBMCs from human patients with ragweed allergy. J Allergy Clin Immunol 2001;108:191-197.
15. Spergel JM, Mizoguchi E, Brewer JP, et al: Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice. J Clin Invest 1998;101:1614-1622.
16. Wang G, Savinko T, Wolff H, et al: Repeated epicutaneous exposures to ovalbumin progressively induce atopic dermatitis-like skin lesions in mice. Clin Exp Allergy 2007;37:151-161.
17. Horner AA, Widhopf GF, Burger JA, et al: Immunostimulatory DNA inhibits IL-4-dependent IgE synthesis by human B cells. J Allergy Clin Immunol 2001;108:417-423.
18. Bohle B, Jahn-Schmid B, Maurer D, et al: Oligodeoxynucleotides containing CpG motifs induce IL-12, IL-18 and IFN-gamma production in cells from allergic individuals and inhibit IgE synthesis in vitro. Eur J Immunol 1999;29:2344-2353.
19. Yamamoto T, Yamamoto S, Kataoka T, et al: Synthetic oligonucleotides with certain palindromes stimulate interferon production of human peripheral blood lymphocytes in vitro. Jpn J Cancer Res 1994;85:775-779.
20. Shirota H, Sano K, Kikuchi T, et al: Regulation of murine airway eosinophilia and Th2 cells by antigen-conjugated CpG oligodeoxynucleotides as a novel antigen-specific immunomodulator. J Immunol 2000;164:5575-5582.
21. Tighe H, Takabayashi K, Schwartz D, et al: Conjugation of immunostimulatory DNA to the short ragweed allergen amb a 1 enhances its immunogenicity and reduces its allergenicity. J Allergy Clin Immunol 2000;106:124-134.
22. Schaller E, Macfarlane AJ, Rupec RA, et al: Inactivation of the F4/80 glycoprotein in the mouse germ line. Mol Cell Biol 2002;22:8035-8043.
23. Guttman-Yassky E, Lowes MA, Fuentes-Duculan J, et al: Major differences in inflammatory dendritic cells and their products distinguish atopic dermatitis from psoriasis. J Allergy Clin Immunol 2007;119:1210-1217.
24. Gomis S, Babiuk L, Godson DL, et al: Protection of chickens against Escherichia coli infections by DNA containing CpG motifs. Infect Immun 2003;71:857-863.
25. Nichani AK, Kaushik RS, Mena A, et al: CpG oligodeoxynucleotide induction of antiviral effector molecules in sheep. Cell Immunol 2004;227:24-37.
26. Sawamura D, Abe R, Goto M, et al: Direct injection of plasmid DNA into the skin induces dermatitis by activation of monocytes through toll-like receptor 9. J Gene Med 2005;7:664-671.